New memory drug moves into Phase 1 clinical study
An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the NIH Blueprint Neurotherapeutics Network, ...
Jan 1, 2016
1
295